Concurrent administration of D-penicillamine and zinc on copper excretion in the rat: a potential treatment for Wilson's disease?

被引：0
|
作者：
Gomez, M [1 ]
Domingo, JL [1 ]
Jones, MM [1 ]
机构：
[1] Univ Rovira & Virgili, Sch Med, Lab Toxicol & Environm Hlth, E-43201 Reus, Spain
来源：
METAL IONS IN BIOLOGY AND MEDICINE, VOL 5 | 1998年 / 5卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：636 / 640
页数：5
相关论文
共 50 条
  • [11] Wilson's disease before and after 5 years of treatment with D-penicillamine
    Zachoval, R
    Glaser, C
    JOURNAL OF HEPATOLOGY, 1998, 29 (03) : 489 - 489
  • [12] Manic Episode Induced by Discontinuance of D-Penicillamine Treatment in Wilson's Disease
    Kenar, Ayse Nur Inci
    Menteseoglu, Husnu
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 24 (04): : 381 - 383
  • [13] Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
    Gromadzka Grażyna
    Karpińska Agata
    Przybyłkowski Adam
    Litwin Tomasz
    Wierzchowska-Ciok Agata
    Dzieżyc Karolina
    Chabik Grzegorz
    Członkowska Anna
    BioMetals, 2014, 27 : 207 - 215
  • [14] Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
    Gromadzka, Grazyna
    Karpinska, Agata
    Przybylkowski, Adam
    Litwin, Tomasz
    Wierzchowska-Ciok, Agata
    Dziezyc, Karolina
    Chabik, Grzegorz
    Czlonkowska, Anna
    BIOMETALS, 2014, 27 (01) : 207 - 215
  • [15] Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson's disease with D-penicillamine treatment failure
    Chen, Dingbang
    Zhou, Xiangxue
    Hou, Haiman
    Feng, Li
    Liu, JunXiu
    Liang, Yinyin
    Lin, Xiaopu
    Zhang, Jiwei
    Wu, Chao
    Liang, Xiuling
    Pei, Zhong
    Li, Xunhua
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (04) : 310 - 316
  • [16] EFFICACY AND SAFETY OF D-PENICILLAMINE AND TRIENTINE FOR THE TREATMENT OF WILSON DISEASE
    Weiss, K. H.
    Schots, M.
    Gotthardt, D. N.
    Ferenci-Foerster, D.
    Maieron, A.
    Stauber, R.
    Reuner, U.
    Houwen, R. H. J.
    Stremmel, W.
    Ferenci, P.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S1 - S1
  • [17] Relapse following withdrawal of D-penicillamine from combination (D-penicillamine plus zinc) therapy in hepatic Wilson disease
    Panda, Kalpana
    Lal, Bikrant B.
    Sood, Vikrant
    Khanna, Rajeev
    Alam, Seema
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (05): : 1017 - 1026
  • [18] Long-term effects of a combination of D-penicillamine and zinc salts in the treatment of Wilson's disease in children
    Chang, Hong
    Xu, Aijing
    Chen, Zhihong
    Zhang, Ying
    Tian, Fei
    Li, Tang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (04) : 1129 - 1132
  • [19] A COMPARISON OF THE EFFECTS OF POLYAMINE LIGANDS AND D-PENICILLAMINE ON URINARY COPPER AND ZINC EXCRETION
    BENSON, GD
    SCHUGAR, HJ
    HEPATOLOGY, 1982, 2 (05) : 736 - 736
  • [20] Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease
    Dziezyc, Karolina
    Litwin, Tomasz
    Chabik, Grzegorz
    Czlonkowska, Anna
    FUNCTIONAL NEUROLOGY, 2015, 30 (04) : 264 - 268
12345